Is "nonusual interstitial pneumonia" an acceptable diagnosis? Behr J. Eur Respir J 2002; 20: 1069-1070 | |
The European Community Respiratory Health Survey II The European Community Respiratory Health Survey II Steering Committee Eur Respir J 2002; 20: 1071-1079 | |
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Kanniess F., Richter K., Janicki S., Schleiss M.B., Jorres R.A., Magnussen H. Eur Respir J 2002; 20: 1080-1087 | |
The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma Buhl R., Hanf G., Soler M., Bensch G., Wolfe J., Everhard F., Champain K., Fox H., Thirlwell J. Eur Respir J 2002; 20: 1088-1094 | |
Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement Ignacio-Garcia J-M., Pinto-Tenorio M., Chocron-Giraldez M.J., Cabello-Rueda F., Lopez-Cozar Gil A.I., Ignacio-Garcia J-M., de Ramon-Garrido E. Eur Respir J 2002; 20: 1095-1101 | |
Variability and lack of predictive ability of asthma end-points in clinical trials Zhang J., Yu C., Holgate S.T., Reiss T.F. Eur Respir J 2002; 20: 1102-1109 | |
Nerve growth factor levels and localisation in human asthmatic bronchi Olgart Hoglund C., de Blay F., Oster J-P., Duvernelle C., Kassel O., Pauli G., Frossard N. Eur Respir J 2002; 20: 1110-1116 | |
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers Hardie J.A., Buist A.S., Vollmer W.M., Ellingsen I., Bakke P.S., Morkve O. Eur Respir J 2002; 20: 1117-1122 | |
Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients Couillard A., Koechlin C., Cristol J.P., Varray A., Prefaut C. Eur Respir J 2002; 20: 1123-1129 | |
Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients Wagenaar M., Je Vos P., Heijdra Y.F., Teppema L.J., Folgering H.T.M. Eur Respir J 2002; 20: 1130-1137 | |
Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study Wadbo M., Lofdahl C-G., Larsson K., Skoogh B.E., Tornling G., Arwestrom E., Bengtsson T., Strom K. Eur Respir J 2002; 20: 1138-1146 | |
Health status measured with the CRQ does not predict mortality in COPD Oga T., Nishimura K., Tsukino M., Sato S., Hajiro T., Ikeda A., Mishima M. Eur Respir J 2002; 20: 1147-1151 | |
Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Robin M., Dong P., Hermans C., Bernard A., Bersten A.D., Doyle I.R. Eur Respir J 2002; 20: 1152-1161 | |
Sex-related interactive effect of smoking and household pets on asthma incidence Chen Y., Dales R., Tang M., Krewski D. Eur Respir J 2002; 20: 1162-1166 | |
Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure Paris C., Galateau-Salle F., Creveuil C., Morello R., Raffaelli C., Gillon J.C., Billon-Galland M.A., Pairon J.C., Chevreau L., Letourneux M. Eur Respir J 2002; 20: 1167-1173 | |
HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells Amicosante M., Berretta F., Franchi A., Rogliani P., Dotti C., Losi M., Dweik R., Saltini C. Eur Respir J 2002; 20: 1174-1178 | |
Single-cell analysis: a novel approach to tumour necrosis factor-α synthesis and secretion in sarcoidosis Pantelidis P., McGrath D.S., Southcott A.M., du Bois R.M. Eur Respir J 2002; 20: 1179-1184 | |
Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo Fehrenbach H., Fehrenbach A., Pan T., Kasper M., Mason R.J. Eur Respir J 2002; 20: 1185-1197 | |
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Pilette C., Ouadrhiri Y., Van Snick J., Renauld J-C., Staquet P., Vaerman J-P., Sibille Y. Eur Respir J 2002; 20: 1198-1205 | |
CC and C chemokine expression in pulmonary sarcoidosis Petrek M., Kolek V., Szotkowska J., du Bois R.M. Eur Respir J 2002; 20: 1206-1212 | |
Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia Watanabe K., Higuchi K., Ninomiya K., Ohshima T., Aritomi T., Kawabata Y., Yoshida M. Eur Respir J 2002; 20: 1213-1219 | |
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Henry M.T., McMahon K., Mackarel A.J., Prikk K., Sorsa T., Maisi P., Sepper R., FitzGerald M.X., O'Connor C.M. Eur Respir J 2002; 20: 1220-1227 | |
Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice Lok S.S., Haider Y., Howell D., Stewart J.P., Hasleton P.S., Egan J.J. Eur Respir J 2002; 20: 1228-1232 | |
Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome Chakravorty I., Cayton R.M., Szczepura A. Eur Respir J 2002; 20: 1233-1238 | |
Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome Alchanatis M., Tourkohoriti G., Kosmas E.N., Panoutsopoulos G., Kakouros S., Papadima K., Gaga M., Jordanoglou J.B. Eur Respir J 2002; 20: 1239-1245 | |
Electroencephalographic spectral analysis: detection of cortical activity changes in sleep apnoea patients Dingli K., Assimakopoulos T., Fietze I., Witt C., Wraith P.K., Douglas N.J. Eur Respir J 2002; 20: 1246-1253 | |
Factors associated with unknown aetiology in patients with community-acquired pneumonia Ewig S., Torres A., Angeles Marcos M., Angrill J., Rano A., de Roux A., Mensa J., Martinez J.A., de la Bellacasa J.P., Bauer T. Eur Respir J 2002; 20: 1254-1262 | |
Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor Kohri K., Ueki I.F., Shim J-J., Burgel P-R., Oh Y-M., Tam D.C., Dao-Pick T., Nadel J.A. Eur Respir J 2002; 20: 1263-1270 | |
Complications of flexible bronchoscopy in children: prospective study of 1,328 procedures de Blic J., Marchac V., Scheinmann P. Eur Respir J 2002; 20: 1271-1276 | |
RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life Schauer U., Hoffjan S., Bittscheidt J., Kochling A., Hemmis S., Bongartz S., Stephan V. Eur Respir J 2002; 20: 1277-1283 | |
Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates Griese M., Neumann M., von Bredow T., Schmidt R., Ratjen F. Eur Respir J 2002; 20: 1284-1291 | |
Lung and thorax development during adolescence: relationship with pubertal status Neve V., Girard F., Flahault A., Boule M. Eur Respir J 2002; 20: 1292-1298 | |
Alveolar epithelial fluid transport in acute lung injury: new insights Sartori C., Matthay M.A. Eur Respir J 2002; 20: 1299-1313 | |
Haemodynamic evaluation of pulmonary hypertension Chemla D., Castelain V., Herve P., Lecarpentier Y., Brimioulle S. Eur Respir J 2002; 20: 1314-1331 | |
Noninvasive ventilation in children Norregaard O. Eur Respir J 2002; 20: 1332-1342 | |
Respiratory intermediate care units: a European survey: European Respiratory Society Task Force on epidemiology of respiratory intermediate care in Europe Members of the Task Force: Corrado A.,Roussos C., Ambrosino N., Confalonieri M., Cuvelier A., Elliott M., Ferrer M., Gorini M., Gurkan O., Muir J.F., Quareni L., Robert D., Rodenstein D., Rossi A., Schoenhofer B., Simonds A.K., Strom K., Torres A., Za S. Eur Respir J 2002; 20: 1343-1350 | |
Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii Yamamoto Y., Osanai S., Fujiuchi S., Yamazaki K., Nakano H., Ohsaki Y., Kikuchi K. Eur Respir J 2002; 20: 1351-1353 | |
Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren Brunekreef B. Eur Respir J 2002; 20: 1354-1355 | |
From the Authors Horak F., Studnicka M., Gartner C., Spengler J.D., Tauber E., Urbanek R., Veiter A., Frischer T. Eur Respir J 2002; 20: 1355 | |